National & Kapodistrian
UNIVERSITY OF ATHENS

Medical School

Home > Vairaktaris Eleftherios

Maxillofacial Surgery Clinic & Research Unit University Hospital "ATTIKON"

Curriculum vitae

Name: Professor Dr. Dr. Eleftherios Vairaktaris

Born: June 10, 1950

Place of birth: Piraeus

Affiliation: Director of the Athens University Clinic for Maxillofacial Surgery
“Attikon” University Hospital
Rimini 1, 12462 Haidari, Greece

E-mail: lvairakt@med.uoa.gr
Tel: 0030 – 210 – 58.31.544
FAX: 0030 – 210 – 67.70.886

ACADEMIC TITLES:
1975 Degree in Dentistry (University of Thessaloniki)
1987 Degree in Medicine (University of Thessaloniki)
1984 PhD in Dentistry (University of Athens)
1992 PhD in Medicine (University of Athens)

POSTGRADUATE EDUCATION ABROAD:
Four and a half years of continuous experience in University Clinics abroad in salaried positions, as follows:

10/1/76 - 1/4/79 three years salaried assistant at the Christian Albrechts University in Kiel, Germany,
6/1/92 – 30/6/92 six months in Hanover, Germany,
1/4/94 – 7/5/95 one year in Tübingen, Germany.

POSTGRADUATE EDUCATION IN GREECE:
Three and a half months in the Emergency Care Unit and the Experimental Surgery Department, 2nd ClinicofSurgery,UniversityofAthens,“Aretaieion” Hospital, Athens.

APPOINTMENTS:

  • Professor of Maxillofacial Surgery, (2009 – present). Surgical Department, School of Medicine, University of Athens, Greece.
  • Director of the Athens University Clinic for Maxillofacial Surgery, “Attikon” University Hospital, Rimini 1, 12462 Haidari, Greece.
  • Scientific Responsible for the Craniomaxillofacial Surgery Unit and Relevant Syndromes, 1st Paediatric Clinic (Director: Professor G. Roussos).

INTERNATIONAL COLLABORATION – DISTINCTION:

  • Reviewer in 11 international scientific journals.
  • Member in the Editorial Board of 3 international scientific journals (Oral Oncology, Oral & Maxillofacial Surgery, International Journal of Clinical Dentistry).
  • 1st prize for best basic science research in the International Congress of Oral Oncology (Amsterdam, May 17 – 20, 2007).
  • Close collaboration with pioneer clinics from Europe.

CLINICAL EXPERIENCE:
1976 – 1979 Scientific assistant at the University Clinic for Oral and Maxillofacial Surgery in Kiel, Germany
1981 Clinic for Oral and Maxillofacial Surgery at the “Laiko” Hospital
1982 - 1986 Consultant at the Clinic for Oral and Maxillofacial Surgery at the “KAT” Hospital
1986 - 1996 Lector, Assistant Professor and Associated Professor University Clinic for Oral and Maxillofacial Surgery at the “Evagelismos” Hospital (excluding a sabbatical for advanced studies)
1996 - 1998 Director of the University Clinic for Oral and Maxillofacial Surgery at the “A & P Kyriakou” Children Hospital
Since 2005 Director of the Clinic for Oral and Maxillofacial Surgery at the University Hospital “Attikon”

MAIN RESEARCH TOPICS:

  • Craniofacial Surgery
  • Plastic and Reconstructive Surgery
  • Oral Cancer Experimental Research
  • Genetic Association Studies
  • Oral Cancer and Diabetes

MEMBERSHIPS:
Member of:

  • the Εuropean Association for Cranio–Maxillofacial Surgery
  • the British Association of Oral and Maxillofacial Surgeons (associate Member).
  • the Deutsche Gesellschaft fuer Mund–, Kiefer– und Gesichtschirurgie (aussserordentliches)
  • 7 Greek Scientific Companies

PUBLICATIONS

  • 167 Scientific Articles:

104 of which are in Journals with Impact Factor
10 of which are Abstracts in Journals with Impact Factor
20 of which are in International Journals without Impact Factor
33 of which are in Greek Scientific Journals

  • More than 175 Lectures in Scientific Congresses
  • 1 Book
  • 2 Book Contributions

No

PART A. List of Publications in International Journals without Impact Factor

1

Ossifying fibroma of the jaws. Review of the literature and report of 16 cases.
N. ZACHARIADES, E. VAIRAKTARIS, S. PAPANIKOLAOU, D. TRIANTAFYLLOY, D. PAPAVASSILIOU, M. MEZITIS.
Int J Oral Surg 1984;13(1):1-6. (continued by Int J Oral Maxillofac Surg)

2

Fractures of the facial skeleton in the edentulous patient.
N. ZACHARIADES, D. PAPAVASSILIOU, D. TRIANTAFYLLOU, E. VAIRAKTARIS, I. PAPADEMETRIOU, M. MEZITIS, A. RAPIDIS.
J Maxillofac Surg 1984;12(6);262-266. (continued by J Craniomaxillofac Surg)

3

The superior orbital fissure syndrome. Review of the literature and report of four cases.
N. ZACHARIADES, E. VAIRAKTARIS, D. PAPAVASILIOU, Ι. PAPADEMETRIOY, M. MEZITIS, D. TRIANTAFYLLOU.
J Maxillofac Surg 1985;13(3):125-128. (continued by J Craniomaxillofac Surg)

4

Traumatic Le Fort III osteotomy.
N. ZACHARIADES, E. VAIRAKTARIS, D. PAPAVASSILIOU, M. MEZITIS, D. TRIANTAFYLLOU.
Br J Oral Maxillofac Surg 1986;24(1):69-71.

5

Aneurysmal bone cyst of the jaws. Review of the literature and report of 2 cases.
N. ZACHARIADES, E. VAIRAKTARIS, M. MEZITIS, D. TRIANTAFYLLOU, D. PAPAVASSILIOU, P. ECONONOPOULOU.
Int J Oral Maxillofac Surg 1986;15(5):534-540.

6

Benign neurogenic tumors of the oral cavity.
N. ZACHARIADES, M. MEZITIS, E. VAIRAKTARIS, D. TRIANTAFYLLOU, C. SKOYRA-KAFOUSIA, E. KONSOLAKI- AGOYRIDAKI, E. HADJIOLOU, D. PAPAVASSILIOU.
Int J Oral Maxillofac Surg 1987;16(1):70-76.

7

Orbital apex syndrome.
N. ZACHARIADES, E. VAIRAKTARIS, D. PAPAVASSILIOU, D. TRIANTAFYLLOY, M. MEZITIS.
Int J Oral Maxillofac Surg 1987;16(3):352-354.

8

Plasma cell myeloma of the jaws.
N. ZACHARIADES, S. PAPANIKOLAOU, D. PAPAVASSILIOU, E. VAIRAKTARIS, D. TRIANTAFYLLOU, M. MEZITIS.
Int J Oral Maxillofac Surg 1987;16(4):510-515.

9

Metastatic tumors to the jaws: A report of seven cases.
N. ZACHARIADES, F. KOUMOURA, E. VAIRAKTARIS, M. MEZITIS.
J Oral Maxillofac Surg 1989;47(9):991-996.

10

Mycobacterial cervical lymphadenitis. A clinicopathological study of 3 cases.
E.VAIRAKTARIS, E.PATSOURIS, N.PAPAGIANNOPOULOS, B.RAGOS, P.DAVARIS.
J Craniomaxillofac Surg 1994;22(3):177-181.

11

Lingual Thyroid: a new surgical approach - A case report.
E. VAIRAKTARIS, T. SEMERGIDIS, P. CHRISTOPOULOU, N. PAPADOGEORGAKIS, C. MARTIS.
J Craniomaxillofac Surg 1994;22(5):307-310.

12

Blood supply to the oral and maxillofacial tissues following radiation therapy: a prospective ultrasonographic study.
T. SEMERGIDIS, E. VAIRAKTARIS, I. IATROU, P. CARAGEORGIS, C. MARTIS.
J Craniomaxillofac Surg 1996;24(1):16-23.

13

Light induced changes in quinolone levels in rat serum and tissues.
C. TESSEROMATIS, A. KOTSIOU, C. MOUROUZIS, T. SARANTEAS, A. POTAMIANOU, E. VAIRACTARIS.
Eur J Drug Metab Pharmacokinet 2004;29(4):231- 233.

14

Untreated 'blow-in' fracture of the orbital floor causing a mucocele: report of an unusual late complication.
E. NKENKE, K. AMANN, T. MAIER, M. BENZ, M. KRAMER, G. HAEUSLER, S. BENZ, J. WILTFANG, EG VAIRAKTARIS, FW NEUKAM, L. HOLBACH.
J Craniomaxillofac Surg 2005;33(4):255-259.

15

Salivary gland manifestations of sarcoidosis: report of three cases.
E. VAIRAKTARIS, S. VASSILIOU, C. YAPIJAKIS, V. PAPAKOSTA, N. KAVANTZAS, C. MARTIS, E. PATSOURIS.
J Oral Maxillofac Surg 2005;63(7):1016-1021.

16

Are factor V and prothrombin mutations associated with increased risk of oral cancer?
E. VAIRAKTARIS, C. YAPIJAKIS, J. WILTFANG, J. RIES, A. VYLLIOTIS, S. DERKA, S. VASILIOU, FW NEUKAM.
Anticancer Res 2005;25(3c):2561-2565.

17

Immediate versus delayed loading of dental implants in the maxillae of minipigs. Part II: histomorphometric analysis.
E. NKENKE, M. FENNER, EG VAIRAKTARIS, FW NEUKAM, M. RADESPIEL-TROGER.
Int J Oral Maxillofac Implants 2005;20(4):540-546.

18

Orbital abscess: visual loss following extraction of a tooth - Case report.
N. ZACHARIADES, E. VAIRAKTARIS, M. MEZITIS, G.RALLIS, C. KOKKINIS, M. MOSCHOS.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100(4):e70-e73.

19

Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer.
E. VAIRAKTARIS, C. YAPIJAKIS, P. KESSLER, A. VYLLIOTIS, J. RIES, J. WILTFANG, S. VASSILIOU, S. DERKA, FW NEUKAM
J Cancer Res Clin Oncol 2006;132(4):219-222.

20

Cell proliferation and apoptosis culminate in early stages of oral oncogenesis.
S. DERKA, E. VAIRAKTARIS, V. PAPAKOSTA, S. VASSILIOU, Y. ACIL, A. VYLLIOTIS, S. SPYRIDONIDOU, AC LAZARIS, C. MOUROUZIS, A. KOKKORI, P. MOULAVASILI, D. PERREA, I. DONTA, C. YAPIJAKIS, E. PATSOURIS.
Oral Oncol 2006;42(5):540-550.

21

Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer.
E. VAIRAKTARIS, C. YAPIJAKIS, S. DERKA, S. VASSILIOU, Z. SEREFOGLOU, A. VYLLIOTIS, J. WILTFANG, I. SPRINGER, E. NKENKE, P. KESSLER, FW NEUKAM.
Eur J Surg Oncol 2006;32(4):455-457.

22

Determination of facial symmetry in unilateral cleft lip and palate patients from three-dimensional data: technical report and assessment of measurement errors.
E. NKENKE, B. LEHNER, M. KRAMER, G. HAEUSLER, S. BENZ, M. SCHUSTER, FW NEUKAM, EG VAIRAKTARIS, J. WURM.
Cleft Palate Craniofac J 2006;43(2):129-137.

23

Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.
E. VAIRAKTARIS, C. YAPIJAKIS, Z. SEREFOGLOU, A. VYLLIOTIS, J. RIES, E. NKENKE, J. WILTFANG, S. DERKA, S. VASSILIOU, I. SPRINGER, P. KESSLER, FW NEUKAM.
Oral Oncol 2006;42(9):888–892.

24

H3 Propranolol serum levels following lidocaine administration in rats with CCL4 induced liver damage.
A. KOTSIOU, M. TSAMOURI, S. ANAGNOSTOPOULOU, M. TZIVRAS, E. VAIRACTARIS, C. TESSEROMATIS.
Eur J Drug Metab Pharmacokinet 2006;31(2):97-101.

25

Nasolabial symmetry following Tennison-Randall lip repair: a three-dimensional approach in 10-year-old patients with unilateral clefts of lip, alveolus and palate.
S. BILWATSCH, M. KRAMER, G. HAEUSLER, M. SCHUSTER, J. WURM, E. VAIRAKTARIS, FW NEUKAM, E. NKENKE.
J Craniomaxillofac Surg 2006;34(5):253-262.

26

The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.
V. PAPAKOSTA, E. VAIRAKTARIS, A. VYLLIOTIS, S. DERKA, E. NKENKE, S. VASSILIOU, A. LAZARIS, C. MOUROUZIS,
G. RALLIS, S. SPYRIDONIDOU, S. ANAGNOSTOPOULOU, D. PERREA, I. DONTA, C. YAPIJAKIS, E.PATSOURIS.
Anticancer Res 2006;26(4B):2957-2962.

27

Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk for oral cancer.
E. VAIRAKTARIS, A. YIANNOPOULOS, A. VYLLIOTIS, C. YAPIJAKIS, S. DERKA, S. VASSILIOU, E. NKENKE, Z. SEREFOGLOU, V. RAGOS, C. TSIGRIS, E. VORRIS, E. CRITSELIS, D. AVGOUSTIDIS, FW NEUKAM, E. PATSOURIS.
Int J Biol Markers 2006;21(4):246-250.

28

FGFR-2 and -3 play an important role in initial stages of oral oncogenesis.
E. VAIRAKTARIS, V. RAGOS, C. YAPIJAKIS, S. DERKA, S. VASSILIOU, E. NKENKE, A. YANNOPOULOS, S. SPYRIDONIDOU, A. VYLLIOTIS, V. PAPAKOSTA, S. LOUKERI, A. LAZARIS, C. TESSEROMATIS, C. TSIGRIS, E. PATSOURIS.
Anticancer Res 2006;26(6B):4217-4221.

29

Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway.
L. GOUTZANIS, E.VAIRAKTARIS, C. YAPIJAKIS, N. KAVANTZAS, E. NKENKE, S. DERKA, S. VASSILIOU, Y. ACIL, P. KESSLER, N. STAVRIANEAS, D. PERREA, I. DONTA, P. SKANDALAKIS, E. PATSOURIS.
Oral Oncol 2007;43(2):165-173.

30

Solitary fibrous tumor in the tongue: Case report and review of the literature.
E. NKENKE, M. FENNER, M. LELL, E. VAIRAKTARIS, FW NEUKAM, G. FALLER.
HNO 2007;55(4):287-292.

31

Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis.
E. VAIRAKTARIS, G. PAPAGEORGIOU, S. DERKA, P. MOULAVASSILI, E. NKENKE, P. KESSLER, S. VASSILIOU, V. PAPAKOSTA,
S. SPYRIDONIDOU, A. VYLLIOTIS, AC LAZARIS, S. ANAGNOSTOPOULOU, C. MOUROUZIS, C. YAPIJAKIS, E. PATSOURIS.
J Cancer Res Clin Oncol 2007;133(4):227-233.

32

The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
Ε. VAIRAKTARIS, C. YAPIJAKIS, Z. SEREFOGLOU, S. DERKA, S. VASSILIOU, E. NKENKE, A. VYLLIOTIS, J. WILTFANG, D. AVGOUSTIDIS, E. CRITSELIS, FW NEUKAM, E. PATSOURIS.
Eur J Surg Oncol 2007;33(4):504-507.

33

Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans.
E. VAIRAKTARIS, C. YAPIJAKIS, A. YIANNOPOULOS, S. VASSILIOU, Z. SEREFOGLOU, A. VYLLIOTIS, E. NKENKE, S. DERKA, E. CRITSELIS, D. AVGOUSTIDIS, FW NEUKAM, E. PATSOURIS.
Oncol Rep 2007;17(4):963-968.

34

Patient centred outcomes comparing transmucosal implant placement with an open approach in the maxilla: a prospective, non-randomized pilot study.
E. NKENKE, S. EITNER, M. RADESPIEL-TRÖGER, E. VAIRAKTARIS, FW NEUKAM, M. FENNER.
Clin Oral Implants Res 2007;18(2):197-203.

35

Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
E. VAIRAKTARIS, C. YAPIJAKIS, S. DERKA, Z. SEREFOGLOU, S. VASSILIOU, E. NKENKE, V. RAGOS, Α. VYLLIOTIS, S. SPYRIDONIDOU, C. TSIGRIS, A. YANNOPOULOS, C. TESSEROMATIS, FW NEUKAM, E. PATSOURIS.
Anticancer Res 2007;27(1A):459-464.

36

Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer.
Z. YU, PM WEINBERGER, C. SASAKI, BL EGLESTON, WF SPEIER 4th, B. HAFFTY, D. KOWALSKI, R. CAMP, D. RIMM, E. VAIRAKTARIS, B. BURTNESS, A. PSYRRI.
Cancer Epidemiol Biomarkers Prev 2007;16(3):553-558.

37

Long-term survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study.
P. KESSLER, G. GRABENBAUER, A. LEHER, A. BLOCH-BIRKHOLZ, E. VAIRAKTARIS, FW NEUKAM, R. SAUER.
Strahlenther Onkol 2007;183(4):184-189.

38

Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Caucasians.
E. VAIRAKTARIS, A. YANNOPOULOS, S. VASSILIOU, Z. SEREFOGLOU, A. VYLLIOTIS, E. NKENKE, E. CRITSELIS,
D. AVGOUSTIDIS, C. YAPIJAKIS, FW NEUKAM, E. PATSOURIS.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(6):796-802.

39

Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.
E. VAIRAKTARIS, C. YAPIJAKIS, A. PSYRRI, S. SPYRIDONIDOU, A. YANNOPOULOS, A. LAZARIS, S. VASSILIOU, E. FEREKIDIS,
A. VYLLIOTIS, E. NKENKE, E. PATSOURIS.
Anticancer Res 2007;27(2):979-984.

40

The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer.
C. YAPIJAKIS, E. VAIRAKTARIS, S. VASSILIOU, A. VYLLIOTIS, E. NKENKE, AM NIXON, S. DERKA, S. SPYRIDONIDOU, E. VORRIS, FW NEUKAM, E. PATSOURIS.
J Cancer Res Clin Oncol 2007;133(10):787-791.

41

Craniectomy and noggin application in an infant model.
IN SPRINGER, PH WARNKE, H. TERHEYDEN, Y. ACIL, A. BUELLHOFF, S. KUCHENBECKER, H. BOLTE, PA RUSSO, EG VAIRAKTARIS, J. WILTFANG.
J Craniomaxillofac Surg 2007;35(3):177-184.

42

Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.
E. VAIRAKTARIS, G. KALOKERINOS, L. GOUTZANIS, S. SPYRIDONIDOU, S. VASSILIOU, S. DERKA, E. NKENKE, C. YAPIJAKIS,
A. VYLLIOTIS, A. LAZARIS, E. PATSOURIS.
Anticancer Res 2007;27(3B):1465-1473.

43

The 1040 C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor (TAFI) is associated with risk for oral cancer.
E. VAIRAKTARIS, C. YAPIJAKIS, E. NKENKE, S. VASSILIOU, A. VYLLIOTIS, AM NIXON, S. DERKA, V. RAGOS, S. SPYRIDONIDOU, C. TSIGRIS, FW NEUKAM, E. PATSOURIS.
Am J Hematol 2007;82(11):1010-1012.

44

Coagulation-related factors Thrombomodulin and protein Z are not associated with risk for oral cancer.
E. VAIRAKTARIS, Z. SEREFOGLOU, C. YAPIJAKIS, E. NKENKE, S. VASSILIOU, S. SPYRIDONIDOU, A. VYLLIOTIS, AM NIXON, FW NEUKAM, E. PATSOURIS.
Anticancer Res 2007;27(4B):2449-2451.

45

High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
E. VAIRAKTARIS, Z. SEREFOGLOU, C. YAPIJAKIS, A. VYLLIOTIS, E. NKENKE, S. DERKA, S. VASSILIOU, D. AVGOUSTIDIS, FW NEUKAM, E. PATSOURIS.
Anticancer Res 2007;27(4B):2493-2498.

46

Conventional Radiographs: Are they still the standard in localisation of shotgun pellets?
P. STOCKMANN, E. VAIRAKTARIS, A. SCHLEGEL, FW NEUKAM, E. NKENKE.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(4):e71-75.

47

Diabetes increases both N-ras and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potential.
E. VAIRAKTARIS, L. GOUTZANIS, G. KALOKERINOS, A. YANNOPOULOS, C. YAPIJAKIS, S. VASSILIOU, S. SPYRIDONIDOU, A. VYLLIOTIS, E. NKENKE, AC LAZARIS, C. TESSEROMATIS, E. PATSOURIS.
In Vivo 2007;21(4):615-621.

48

Diabetes Does Not Influence Oral Oncogenesis Through Fibroblast Growth Factor Receptors.
E. VAIRAKTARIS, L. GOUTZANIS, E. NKENKE, S. SPYRIDONIDOU, S. VASSILIOU, S. DERKA, A. VYLLIOTIS, C. YAPIJAKIS, AC LAZARIS, P. STRANTZIAS, E. KALIMERAS, E. PATSOURIS.
In Vivo 2007;21(4):623-628.

49

Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.
E. VAIRAKTARIS, C. YAPIJAKIS, C. TSIGRIS, S. VASSILIOU, S. DERKA, E. NKENKE, S. SPYRIDONIDOU, A. VYLLIOTIS, E. VORRIS, V. RAGOS, FW NEUKAM, E. PATSOURIS.
Acta Oncol 2007;46(8):1097-1102.

50

Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII.
E. VAIRAKTARIS, S. VASSILIOU, C. YAPIJAKIS, S. SPYRIDONIDOU, A. VYLLIOTIS, S. DERKA, E. NKENKE, G. FOURTOUNIS,
F. NEUKAM, E. PATSOURIS.
Oncol Rep 2007;18(6):1537-1543.

51

Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis.
E. VAIRAKTARIS, L. GOUTZANIS, E. NKENKE, S. SPYRIDONIDOU, S. VASSILIOU, S. DERKA, A. VYLLIOTIS, C. YAPIJAKIS, A. LAZARIS, P. STRANTZIAS, E. KALIMERAS, E. PATSOURIS.
In Vivo 2007;21(5):745-750.

52

EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis.
E. VAIRAKTARIS, S. LOUKERI, S. VASSILIOU, E. NKENKE, S. SPYRIDONIDOU, A. VYLLIOTIS, V. PAPAKOSTA, AC LAZARIS, G. AGROGIANNIS, C. YAPIJAKIS, D. PERREA, E. PATSOURIS.
In Vivo 2007;21(5):791-796.

53

Evaluation of apoptosis in nasal and buccal cells of septic patients.
S. VASSILIOU, C. YAPIJAKIS, S. DERKA, C. TESSEROMATIS, A. PSYRRI, P. ANTONAKAKIS, L. GOUTZANIS, M. KONSTADOULAKIS, G. ANDROULAKIS, E. VAIRAKTARIS.
In Vivo 2007;21(5):901-904.

54

Proof of Direct Radiogenic Destruction of Collagen in Vitro.
Y. ACIL, IN SPRINGER, P. NIEHOFF, V. GASSLING, HW WARNKE, S. ACMAZ, TT SONMEZ, B. KIMMIG, L. VAIRAKTARIS, J. WILTFANG.
Strahlenther Onkol 2007;183(7):374-379.

55

Increased risk for oral cancer in diabetic animals is not associated with c-jun activation pathway.
E. VAIRAKTARIS, L. GOUTZANIS, G. KALOKERINOS, S. VASSILIOU, S. SPYRIDONIDOU, D. AVGOUSTIDIS, P. STRANZIAS, AC LAZARIS, G. PAPAGEORGIOU, V. RAGOS, C. YAPIJAKIS, E. PATSOURIS.
J Craniomaxillofac Surg 2007;35(8):382-387.

56

The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancer.
E. VAIRAKTARIS, Z. SEREFOGLOU, C. YAPIJAKIS, P. STATHOPOULOS, S. VASSILIOU, S. DERKA, E. NKENKE, A. VYLLIOTIS, V. RAGOS, FW NEUKAM, E. PATSOURIS.
Anticancer Res 2007;27(6):3981-3986.

57

The Interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer.
E. VAIRAKTARIS, ZC SEREFOGLOU, C. YAPIJAKIS, A. CHATZITHEOFYLAKTOU, S. VASSILIOU, E. NKENKE, A. VYLLIOTIS, S. SPYRIDONIDOU, FW NEUKAM, E. PATSOURIS.
Anticancer Res 2007;27(6):4011-4014.

58

A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer.
E. VAIRAKTARIS, C. YAPIJAKIS, E. NKENKE, ZC. SEREFOGLOU, A. CHATZITHEOFYLAKTOU, S. VASSILIOU, S. DERKA, A. VYLLIOTIS, D. PERREA, FW NEUKAM E. PATSOURIS.
Anticancer Res 2007;27(6):4027-4030.

59

Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
E. VAIRAKTARIS, C. YAPIJAKIS, S. VASSILIOU, S. DERKA, E. NKENKE, Z. SEREFOGLOU, E. VORRIS, A. VYLLIOTIS, V. RAGOS, F. NEUKAM, E. PATSOURIS.
Anticancer Res 2007;27(6):4095-4100.

60

The platelet glycoprotein Ibα VNTR polymorphism is associated with risk for oral cancer.
E. VAIRAKTARIS, ZC SEREFOGLOU, C. YAPIJAKIS, S. VASSILIOU, E. NKENKE, D. AVGOUSTIDIS, A. VYLLIOTIS, P. STATHOPOULOS, FW NEUKAM, E. PATSOURIS.
Anticancer Res 2007;27(6):4121-4126.

61

Diabetes and Oral Oncogenesis.
E. VAIRAKTARIS, S. SPYRIDONIDOU, L. GOUTZANIS, A. VYLLIOTIS, A. LAZARIS, I. DONTA, D. PERREA, C. YAPIJAKIS, E. PATSOURIS.
Anticancer Res 2007;27(6):4185-4193.

62

Diabetes enhances cell proliferation but not Bax/Bcl-2 mediated apoptosis during oral oncogenesis.
E. VAIRAKTARIS, G. KALOKERINOS, L. GOUTZANIS, C. YAPIJAKIS, S. DERKA, S. VASSILIOU, S. SPYRIDONIDOU, A. VYLLIOTIS, E. NKENKE, AC LAZARIS, E. PATSOURIS.
Int J Oral Maxillofac Surg 2008;37(1):60-65.

63

Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma. Long-term survival in a prospective, non-randomized study.
P. KESSLER, G. GRABENBAUER G, A. LEHER, A. BLOCH-BIRKHOLZ, E. VAIRAKTARIS, FW NEUKAM.
Br J Oral Maxillofac Surg 2008;46(1):1-5.

64

Expression of MAGE - A12 in oral squamous cell carcinoma.
N. MOLLAOGLU, E. VAIRAKTARIS, E. NKENKE, FW NEUKAM, J. RIES.
Dis Markers 2008;24(1):27-32,

65

Expression of melanoma associated antigens in oral squamous cell carcinoma.
J. RIES, E. VAIRAKTARIS, J. WILTFANG, N. MOLLAOGLU, FW NEUKAM, E. NKENKE.
J Oral Pathol Med 2008;37(2):88-93.

66

Vascular mapping of head and neck: Computed tomography versus digital subtraction angiography.
MK KRAMER, E. VAIRAKTARIS, E. NKENKE, A. SCHLEGEL, FW NEUKAM, M. LELL.
J Oral Maxillofac Surg 2008;66(2):302-307.

67

The interleukin-10 (-1082A/G) Polymorphism is Strongly Associated with Increased Risk for Oral Squamous Cell Carcinoma.
E. VAIRAKTARIS*, C. YAPIJAKIS*, Z. SEREFOGLOU, S. DERKA, S. VASSILIOU, E. NKENKE, A. VYLLIOTIS, S. SPYRIDONIDOU, FW NEUKAM, E. PATSOURIS.
Anticancer Res 2008;28(1Α):309-314.

68

A DNA Polymorphism of Stromal-derived Factor-I is associated with Advanced Stages of Oral Cancer.
E. VAIRAKTARIS, A. VYLLIOTIS, S. SPYRIDONIDOU, S. DERKA, S. VASSILIOU, E. NKENKE, C. YAPIJAKIS, Z. SEREFOGLOU, FW NEUKAM, E. PATSOURIS.
Anticancer Res 2008;28(1A):271-276.

69

A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
E. VAIRAKTARIS, S. VASSILIOU, E. NKENKE, Z. SEREFOGLOU, S. DERKA, C. TSIGRIS, A. VYLLIOTIS, C. YAPIJAKIS, FW NEUKAM, E.PATSOURIS.
Eur J Surg Oncol 2008;34(4):450-455.

70

Effects of Topographical Surface Modifications of Electron Beam Melted (EBM) Ti-6A1-4V titanium on human fetal osteoblasts.
S. PONADER, E. VAIRAKTARIS, P. HEINL, CV WILMOWSKY, A. ROTTMAIR, C. KOERNER, RF SINGER, S. HOLST, KA SCHLEGEL, FW NEUKAM, E. NKENKE.
J Biomed Mater Res A 2008;84(4):1111-1119. (PMID: 17685409)

71

Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.
E. VAIRAKTARIS, L. GOUTZANIS, S. VASSILIOU, S. SPYRIDONIDOU, E. NKENKE, G. PAPAGEORGIOU, P. STRANTZIAS, AC LAZARIS, C. YAPIJAKIS, E. PATSOURIS.
J Cancer Res Clin Oncol 2008;134(3):337-344.

72

Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma.
T. TOYOSHIMA, E. VAIRAKTARIS, E. NKENKE, KA SCHLEGEL, FW NEUKAM, J. RIES.
J Cancer Res Clin Oncol 2008;134(4):515-521.

73

The hamster model of sequential oral oncogenesis.
E. VAIRAKTARIS, S. SPYRIDONIDOU, V. PAPAKOSTA, A. VYLLIOTIS, A. LAZARIS, D. PERREA, C. YAPIJAKIS, E. PATSOURIS.
Oral Oncol 2008;44(4):315-324.

74

Computer-assisted orbital floor reconstruction: Use of a CAD/CAM implant with intraoperative contact-free 3D endo- and exophthalmometry.
T. KUEHNEL, E. VAIRAKTARIS, C. ALEXIOU, A. SCHLEGEL, FW NEUKAM, E. NKENKE.
HNO 2008;56(11):1142-1147.

75

Enophthalmos correction in complex orbital floor reconstruction: Computer-assisted, intraoperative, non-contact, optical 3D support.
TV KUEHNEL, E. VAIRAKTARIS, A. SCHLEGEL, FW NEUKAM, B. KUEHNEL, LM HOHLBACH, E. NKENKE.
Ophthalmologe 2008;105(6):578-583.

76

Gene Expression Polymorphisms of Interleukins -1β, -4, -6, -8, -10, and Tumor Necrosis Factors -α, -β:
Regression Analysis of their Effect upon Oral Squamous Cell Carcinoma.
E. VAIRAKTARIS, C. YAPIJAKIS, Z. SEREFOGLOU, D. AVGOUSTIDIS, E. CRITSELIS, S. SPYRIDONIDOU, A. VYLLIOTIS, S. DERKA, S. VASSILIOU, E. NKENKE, E. PATSOURIS.
J Cancer Res Clin Oncol 2008;134(8):821-832.

77

Ιnfluence of residual alveolar bone height on implant stability in the maxilla: An experimental animal study.
E. FENNER, E. VAIRAKTARIS, P. STOCKMANN, KA SCHLEGEL, FW NEUKAM, E. NKENKE.
Clin Oral Implants Res 2008;20(6):555-559.

78

Effects of bioactive glass and beta-TCP containing three-dimensional laser sintered polyetheretherketone composites on osteoblasts in vitro.
C. von WILMOWSKY, E. VAIRAKTARIS, D. POHLE, T. RECHTENWALD, R. LUTZ, H. MUENSTEDT, G. KOLLER, M. SCHMIDT, FW NEUKAM, KA SCHLEGEL, E. NKENKE.
J Biomed Mater Res A 2008;87(4):896-902.

79

Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.
E. VAIRAKTARIS, C. YAPIJAKIS, A. VYLLIOTIS, S. DERKA, S. VASSILIOU, E. NKENKE, Z. SEREFOGLOU, V. RAGOS, E. CRITSELIS, D. AVGOUSTIDIS, FW NEUKAM, E. PATSOURIS.
Anticancer Research 2008;28(3A):1675-1679.

80

In vitro response of hFOB cells to pamidronate modified sodium silicate coated cellulose scaffolds.
S. PONADER, H. BRANDT, E. VAIRAKTARIS, C. von WILMOWSKY, E. NKENKE, KA SCHLEGEL, FW NEUKAM, S. HOLST, FA MUELLER, P. GREIL.
Colloids Surf B Biointerfaces 2008;64(2):275-283.

81

H-ras and c-fos exhibit similar expression patterns during stages of oral oncogenesis.
E. VAIRAKTARIS, V. PAPAKOSTA, S. DERKA, S. VASSILIOU, E. NKENKE, S. SPYRIDONIDOU, A. VYLLIOTIS, AC LAZARIS, A. KOKKORI, P. MOULAVASSILI, S. LOUKERI, D. PERREA, I. DONTAS, C. YAPIJAKIS, E. PATSOURIS.
In Vivo 2008;22(5):621-628.

82

Prevalence of HPV types in a cohort of Greeks with clinical indication of infection.
C. YAPIJAKIS, M. ADAMOPOULOU, G. ANTONOPOULOS, N. KOUFALIOTIS, E. VAIRAKTARIS.
Anticancer Res 2008;28(4B):2233-2237.

83

Delayed Appearance of Diplopia due to Orbital Emphysema after repair of Orbital Fractures.
E. VAIRAKTARIS, MM MOSCHOS, S. VASSILIOU, E. KALIMERAS, D. AVGOUSTIDIS, MN MOSCHOS.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106(1):e8-e10.

84

Genetic association of cytokine DNA polymorphisms with head and neck cancer. (Review)
Z. SEREFOGLOU, C. YAPIJAKIS, Ε. ΝΚΕΝΚΕ, E. VAIRAKTARIS.
Oral Oncol 2008;44(12):1093-1099.

85

HPV detection rate in saliva may depend on the immune system efficiency.
M. ADAMOPOULOU, E. VAIRAKTARIS, V. PANIS, E. NKENKE, FW NEUKAM, C. YAPIJAKIS.
In Vivo 2008;22(5):599-602.

86

Metastases following Biopsy of Oral carcinoma in Hamsters and the Role of Prebiopsy Bleomycin.
G. RALLIS, C. MOUROUZIS, V. PAPAKOSTA, I. DONTA, D. PERREA, E. PATSOURIS , E. VAIRAKTARIS.
Anticancer Res 2008;28(4B):2253-7.

87

Influence of residual alveolar bone height on osseointegration of implants in the maxilla: A pilot study.
FENNER M, VAIRAKTARIS E, FISCHER K, SCHLEGEL KA, NEUKAM FW, NKENKE E.
Clin Oral Implants Res 2009;20(6):555-559.

88

A common 9bp Deletion in the Ataxia-Telangiectasia-Mutated Gene is not associated with oral cancer.
S. SPYRIDONIDOU, C. YAPIJAKIS, E. NKENKE, T. TOYOSHIMA, A. VYLLIOTIS, Z. SEREFOGLOU, FW NEUKAM, E. PATSOURIS, E. VAIRAKTARIS.
Anticancer Res 2009;29(8):3191-3193.

89

Association of Leptin -2548G/A and Leptin Receptor Q223R Polymorphisms with Increased Risk for Oral Cancer.
C. YAPIJAKIS, M. KECHAGIADAKIS, E. NKENKE, Z. SEREFOGLOU, D. AVGOUSTIDIS, A. VYLLIOTIS, D. PERREA, FW NEUKAM, E. PATSOURIS, E. VAIRAKTARIS.
J Cancer Res Clin Oncol 2009;135(4):603-612.

90

Haematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: Preliminary results.
T. TOYOSHIMA, E. VAIRAKTARIS, E. NKENKE, KA SCHLEGEL, FW NEUKAM, J. RIES.
Anticancer Res 2009;29(1):291-297.

91

Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer.
E. VAIRAKTARIS, Z. SEREFOGLOU*, D. AVGOUSTIDIS, C. YAPIJAKIS, E. CRITSELIS, A. VYLLIOTIS, S. SPYRIDONIDOU, S. DERKA, S. VASSILIOU, E. NKENKE, E. PATSOURIS.
Oral Oncol 2009;45(3):247-253.

92

Prognostic impact of blood transfusion in patients undergoing primary surgery and free-flap reconstruction for oral squamous cell carcinoma.
M. FENNER, E. VAIRAKTARIS, E. NKENKE, V. WEISBACH, FW NEUKAM, M. RADESPIEL-TRÖGER.
Cancer 2009;115(7):1481-1488.

93

Orbital cellulitis, orbital subperiosteal and intraorbital abscess: Report of three cases and review of the literature.
E. VAIRAKTARIS, MM MOSCHOS, S. VASSILIOU, S. BALTATZIS, E. KALIMERAS, D. AVGOUSTIIDIS, MN MOSCHOS.
J Craniomaxillofac Surg 2009;37(3):132-136.

94

Diabetes enhances the expression of H-ras and suppresses the expression of EGFR leading to increased cell proliferation.
E. VAIRAKTARIS, L. GOUTZANIS, C. YAPIJAKIS, S. VASSILIOU, S. SPYRIDONIDOU, A. VYLLIOTIS, E. NKENKE, AC LAZARIS, P. STRANTZIAS, E. PATSOURIS.
Histol Histopathol 2009;24(5):531-539.

95

A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma.
J. RIES, N. MOLLAOGLU, T. TOYOSHIMA, E. VAIRAKTARIS, FW NEUKAM, S. PONADER, E. NKENKE.
Dis Markers. 2009;27(2):75-84.

96

Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
C. YAPIJAKIS, Z. SEREFOGLOU, A. VYLLIOTIS, E. NKENKE, S. DERKA, S. VASSILIOU, D. AVGOUSTIDIS, FW NEUKAM, E. PATSOURIS, E. VAIRAKTARIS.
Anticancer Res. 2009;29(6):2379-86.

97

T. TOYOSHIMA, F. KOCH, P. KAEMMERER, E. VAIRAKTARIS, B. AL-NAWAS, W. WAGNER.
Expression of cytokeratin 17 mRNA in oral squamous cell carcinoma cells obtained by brush biopsy: preliminary results.
J Oral Pathol Med. 2009;38(6):530-4.

98

Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene.
E. VAIRAKTARIS, S. VASSILIOU, D. AVGOUSTIDIS, P. STATHOPOULOS, T. TOYOSHIMA, C. YAPIJAKIS.
J Oral Maxillofac 2009;67(9):2009-2012.

99

Osteocutaneous free flap including medial and lateral scapular crests: technical
aspects, viability, and donor site morbidity.
E. NKENKE, E. VAIRAKTARIS, F. STELZLE, FW NEUKAM, P. STOCKMANN, R. LINKE.
J Reconstr Microsurg. 2009;25(9):545-553.

100

No reduction in complication rate by stay in the intensive care unit for patients undergoing surgery for head and neck cancer and microvascular reconstruction.
E. NKENKE, E. VAIRAKTARIS, F. STELZLE, FW NEUKAM, M. St PIERRE..
Head Neck 2009;31(11):1461-9.

101

In vitro behavior of layer-by-layer deposited molecular oligoelectrolyte films on Ti-6Al-4V surfaces.
S. PONADER, K. ROSENLEHNER, E. VAIRAKTARIS, C von WILMOWSKY, KA SCHLEGEL, FW NEUKAM, CD SCHMIDT, T. SCHUNK, A. HIRSCH, E. NKENKE.
J Mater Sci Mater Med 2009;20(12):2455-2463.

102

Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
J. RIES, N. MOLLAOGLU, E. VAIRAKTARIS, FW NEUKAM, E. NKENKE.
Anticancer Res. 2009;29(12):5125-30.

103

Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up.
P. STOCKMANN, E. VAIRAKTARIS, F. WEHRHAN, M. SEISS, S. SCHWARZ, B. SPRIEWALD, FW NEUKAM, E. NKENKE.
Support Care Cancer 2010;18(4):449-460.

104

Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.
P. STOCKMANN, FM HINKMANN, MM LELL, M, FENNER, E. VAIRAKTARIS, FW NEUKAM, E. NKENKE.
Clin Oral Investig. 2010;14(3):311-317.

No

PART B. List of Publications in International Journals without Impact Factor

1

Cerebral abscess and meningitis complicated by residual mandibular ankylosis. A study of the routes that spread the infection.
Ν. ZACHARIADES, E. VAIRAKTARIS, M. MEZITIS, D. TRIANTAFYLLOU, D. PAPAVASSILIOU.
J Oral Med 1986;41(1):14–20. (Discontinued)

2

Bilateral static bone cyst associated with fracture of the mandible.
N. ZACHARIADES, C. PATRINOY, E. VAIRAKTARIS, M. MEZITIS, D. TRIANTAFYLLOU, D. PAPAVASSILIOU.
Chir Testa e Collo 1986;3:18–22.

3

Chondrosarcoma of the orofacial region. Review of the literature and report of two cases.
N. ZACHARIADES, E. VAIRAKTARIS, M. MEZITIS, D. TRIANTAFYLLOU, D. PAPAVASSILIOU.
Rev Stomatol Chir Maxillofac 1987;88(5):382–387.

4

Le Fort I Osteotomy in a Patient with Albright Syndrome.
E. VAIRAKTARIS, G. RALLIS, N. ZACHARIADES.
Chir Testa e Collo 1990;7:59–63.

5

Adult respiratory distress syndrome in patients with maxillofacial injuries. Report of three cases.
M. MEZITIS, N. ZACHARIADES, E. VAIRAKTARIS.
Chir Testa e Collo 1991;8:49–57.

6

Aneurysmal Bone Cyst of the Mandible. A. Case Report.
E. VAIRAKTARIS, P. ECONOMOPOULOU, S. SOTIRIADOU.
Chir Testa e Collo 1992;9:21–27.

7

Primary Oral Kaposi's Sarcoma in a non–AIDS Patient.
E.VAIRAKTARIS, P.ECONOMOPOULOU, T.SEMERGIDIS, C.MARTIS.
Chir Testa e Collo 1993;10:53–59.

8

An unusual case of a huge Mixed parotid tumour.
T. SEPHERIADOU, E. VAIRAKTARIS, E. ELEFTHERIADIS, E. BAZOPOULOU, C. MARTIS.
Chir Testa e Collo 1993;10:47–51.

9

Leiomyosarcoma of the Mandible.
E. VAIRAKTARIS, T. SEPHERIADOU, V. RAGOS, P. KARAGIORGIS, G. PANTAZIS, P. CHRISTODOULOU, C. MARTIS.
Chir Testa e Collo 1994;11:11–19.

10

Eagle's syndrome masked by TMJ pathosis: Report of 2 cases.
E. VAIRAKTARIS, T.SEPHERIADOU, V.RAGOS, T.SEMERGIDIS, S. VASSILIOU.
Chir Testa e Collo 1994;11:69–75.

11

Non ossifying fibroma of the mandible. A clinical and histologic study of one case.
Ε. VAIRAKTARIS, E. PATSOURIS, T. SEMERGIDIS, I. SIDERIS, C. MARTIS.
Chir Testa e Collo 1994;11:3–9.

12

Peripheral ameloblastoma. A clinical and histologic study of one case.
Ε. VAIRAKTARIS, E. PATSOURIS, B. RAGOS, G. PANTASIS, S. VASSILIOU.
Chir Testa e Collo 1994;11:59–68.

13

Tödliche Lungenkomplikation als Folge eines odontogen Logenabszesses.
Ε. VAIRAKTARIS, I. BELENIS, TH. SEMERGIDIS, B. RAGOS, N. PAPADOGEORGAKIS.
Dtsch Z Mund Kiefer Gesichtschir 1994;18:175–178.

14

Laryngeal insufficiency as a post–traumatic complication of facial skull injury.
E. VAIRAKTARIS, M. MEZITIS, D. TRIANTAFYLLOU, N. ZACHARIADES.
Aktuelle Traumatol 1994;24(7):279–280.

15

Alkoholkonsum und Verkehrsunfälle – eine statistische Erhebung in Südwestgriechenland
F. SKERPANI, E. VAIRAKTARIS, E. MISSIRLIS, M. MARAGOUDAKIS
Journal der Deutschen Gesellschaft für Plastische und Wiederherstellungschirurgie 2001;23:62-65.

16

Influence of plateleled rich plasma (PRP) on bone regeneration.
J WILTFANG, SM HECKMANN, E. VAIRAKTARIS, AK SCHLEGEL.
Ukranian Journal of Dentistry 2004;2(39):15–19.

17

State of the art of fusion of computed tomography data and optical 3D images.
E. NKENKE, E. VAIRAKTARIS, FW NEUKAM, A. SCHLEGEL, M. STAMMINGER.
Int J Comput Dent 2007;10(1):11–24.

18

Abundance and localization of skeletal muscle–related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis.
E. VAIRAKTARIS, P. MOULAVASSILI, S. LOUKERI, S. SPYRIDONIDOU, C. YAPIJAKIS, S. VASSILIOU, E. NKENKE, A. VYLLIOTIS, V. PAPAKOSTA, AC LAZARIS, E. PATSOURIS.
J Musculoskeletal Neuronal Interact 2007;7(2):185–190.

19

Three-dimensional analysis of changes of the malar-midfacial region after LeFort I osteotomy and maxillary advancement.
E. NKENKE, E. VAIRAKTARIS, M. KRAMER, A. SCHLEGEL, A. HOLST, U. HIRSCHFELDER, J. WILTFANG, FW NEUKA, M STAMMINGER.
Oral Maxillofac Surg 2008;12(1):5-12.

20

Three-dimensional analysis of facial symmetry in cleft lip and palate patients using optical surface data.
I. STAUBER, E. VAIRAKTARIS, A. HOLST, M. SCHUSTER, U. HIRSCHFELDER, FW NEUKAM, E. NKENKE.
J Orofac Orthop. 2008;69(4):268-282.

PART C. ABSTRACTS

1. "The radicality of functional neck dissection: experience from 540 cases of composite operations".
C. MARTIS, E. VAIRAKTARIS, K. MARTIS.
Abstract in J Craniomaxillofac Surg 1992;20(6 Suppl 1):1–73.

2. “Secondary correction of fronto–naso–orbital injuries”.
T. SEMERGIDIS, E. VAIRAKTARIS, I. IATROU, C. MARTIS.
Abstract in J Craniomaxillofac Surg 1996;24:105.

3. “Malignant tumours of the salivary glands: surgical approach”.
T. SEMERGIDIS, E. VAIRAKTARIS, I. IATROU.
Abstract in Br J Surg 1997;84(2):80.

4. “Basal cell carcinoma of the face”.
E. VAIRAKTARIS, M. ALEXOPOULOU M., T. SEMERGIDIS.
Abstract in Br J Surg 1997;84(2):81.

5. “Surgical treatment of oronasal defects resulting from cocaine abuse”.
T. SEMERGIDIS, S. VASSILIOU, R. MEYER, E. VAIRAKTARIS.
Abstract in Int J Oral Maxillofac Surg 2001;30(A):S72.

6. "Prevalence of thrombophilic gene mutations in patients with oral cancer". C. YAPIJAKIS, E. VAIRAKTARIS, J. WILTFANG, J. RIES, A. VYLLIOTIS, FW. NEUKAM.
Abstract in Eur J Hum Genet 2004;12(S1):193.

7. "Common DNA polymorphisms in thrombophilia–related genes predispose for oral cancer".
C. YAPIJAKIS, E. VAIRAKTARIS, Z. SEREFOGLOU, A. VYLLIOTIS, E. NKENKE, P. KESSLER, FW. NEUKAM.
Abstract in Eur J Hum Genet 2006;14(S1):225.

8. "Genetic association studies reveal significant predisposition for oral cancer in Europeans".
C. YAPIJAKIS, Z. SEREFOGLOU, A. VYLLIOTIS, S. SPYRIDONIDOU, D. AVGOUSTIDIS, E. CRITSELIS, E. NKENKE, FW. NEUKAM, E. VAIRAKTARIS.
Abstract in Int J Mol Med 2006;18(S1):S86.

9. "Role of oncogenes and tumour suppressor genes in sequential stages of oral oncogenesis in an experimental animal model".
E.VAIRAKTARIS, V. PAPAKOSTA, S. SPYRIDONIDOU, A.VYLLIOTIS, P. STRANTZIAS, E. VORRI, D. AVGOUSTIDIS, A. LAZARIS, D. PERREA, N. KAVANTZAS, I. DONTA, S. DERKA, S. VASSILIOU, C. YAPIJAKIS, E. PATSOURIS.
Abstract in Oral Oncol 2007;2(S1):204.

10. "Risk for oral squamous cell carcinoma is inherited in one third of Europeans".
C. YAPIJAKIS, Z. SEREFOGLOU, A. VYLLIOTIS, S. SPYRIDONIDOU, M. KECHAGIADAKIS, D. AVGOUSTIDIS, E. CRITSELIS, A. CHATZITHEOFYLAKTOU, A. NIXON, E. VORRIS, E. NKENKE, F.W. NEUKAM, E. PATSOURIS, E.VAIRAKTARIS.
Abstract in Oral Oncol 2007;2(S1):126.